Source: Engadget
“After initially refusing to even review it, the US Food and Drug Administration (FDA) has approved Moderna’s mRNA seasonal flu vaccine, the pharmaceutical company announced in a press release. Known as mFlusiva (or mRNA-1010), the immunization is effective against the four most common strains of influenza and has been in human testing trials since 2021. Those variants cause up to five million severe flu cases every year and result in as many as 650,000 respiratory deaths annually, the World Health Organization (WHO) wrote in 2017. The vaccine is approved for adults aged 50 and over.” (08/06/26)
https://www.engadget.com/2231390/fda-approves-modernas-mrna-flusiva-vaccine/